FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.92
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 10.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -3.61x
- Price / sales
- 7.95x
- Price / cash flow
- -3.43x
Enterprise value
- Enterprise value
- $167.7M
- EV / sales
- 4.56x
- EV / EBITDA
- -2.68x
- EV / EBIT
- -2.45x
- Market cap
- $292.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026